BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1537861)

  • 1. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk.
    Dymecki SM; Zwollo P; Zeller K; Kuhajda FP; Desiderio SV
    J Biol Chem; 1992 Mar; 267(7):4815-23. PubMed ID: 1537861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription of the blk gene in human B lymphocytes is controlled by two promoters.
    Lin YH; Shin EJ; Campbell MJ; Niederhuber JE
    J Biol Chem; 1995 Oct; 270(43):25968-75. PubMed ID: 7592787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells.
    Dymecki SM; Niederhuber JE; Desiderio SV
    Science; 1990 Jan; 247(4940):332-6. PubMed ID: 2404338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk).
    Drebin JA; Hartzell SW; Griffin C; Campbell MJ; Niederhuber JE
    Oncogene; 1995 Feb; 10(3):477-86. PubMed ID: 7845672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific recognition of the blk promoter by the B-lymphoid transcription factor B-cell-specific activator protein.
    Zwollo P; Desiderio S
    J Biol Chem; 1994 May; 269(21):15310-7. PubMed ID: 8195169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of B lymphoid cell lines for membrane immunoglobulin-stimulated tyrosine phosphorylation and src-family tyrosine kinase mRNA expression.
    Law DA; Gold MR; DeFranco AL
    Mol Immunol; 1992; 29(7-8):917-26. PubMed ID: 1378935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk.
    Islam KB; Rabbani H; Larsson C; Sanders R; Smith CI
    J Immunol; 1995 Feb; 154(3):1265-72. PubMed ID: 7822795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of protein tyrosine kinases in the Ig complex of anti-mu-sensitive and anti-mu-resistant B-cell lymphomas: role of the p55blk kinase in signaling growth arrest and apoptosis.
    Yao XR; Scott DW
    Immunol Rev; 1993 Apr; 132():163-86. PubMed ID: 8349295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes.
    Malek SN; Desiderio S
    J Biol Chem; 1993 Oct; 268(30):22557-65. PubMed ID: 8226767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor NF-kappaB/p50 interacts with the blk gene during B cell activation.
    Zwollo P; Rao S; Wallin JJ; Gackstetter ER; Koshland ME
    J Biol Chem; 1998 Jul; 273(29):18647-55. PubMed ID: 9660839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization.
    Trapani JA; Dawson M; Apostolidis VA; Browne KA
    Immunogenetics; 1994; 40(6):415-24. PubMed ID: 7959953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation.
    Texido G; Su IH; Mecklenbräuker I; Saijo K; Malek SN; Desiderio S; Rajewsky K; Tarakhovsky A
    Mol Cell Biol; 2000 Feb; 20(4):1227-33. PubMed ID: 10648608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
    Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
    Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7.
    Wang J; Walker H; Lin Q; Jenkins N; Copeland NG; Watanabe T; Burrows PD; Cooper MD
    Genomics; 1996 Apr; 33(2):167-76. PubMed ID: 8660964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma.
    Yao XR; Scott DW
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.
    Compeer EB; Janssen W; van Royen-Kerkhof A; van Gijn M; van Montfrans JM; Boes M
    Oncotarget; 2015 May; 6(13):10759-71. PubMed ID: 25926555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
    Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
    J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters.
    Adler HT; Reynolds PJ; Kelley CM; Sefton BM
    J Virol; 1988 Nov; 62(11):4113-22. PubMed ID: 2845126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.